Beneficial effects of minocycline and botulinum toxin-induced constraint physical therapy following experimental traumatic brain injury

Neurorehabil Neural Repair. 2013 Nov-Dec;27(9):889-99. doi: 10.1177/1545968313491003. Epub 2013 Jun 18.

Abstract

Background: Effective recovery from functional impairments caused by traumatic brain injury (TBI) requires appropriate rehabilitation therapy. Multiple pathways are involved in secondary injury and recovery suggesting a role for multimodal approaches.

Objective: Here, we examined the efficacy of the anti-inflammatory agent minocycline and botulinum toxin (botox)-induced limb constraint with structured physical therapy, delivered alone or in combination, after a severe TBI produced by a controlled cortical impact in rats.

Methods: Minocycline was administered at 25 mg/kg daily for 2 weeks beginning 1 day after TBI or sham surgery. For constraint/physical therapy, botox-type A was injected into the nonaffected forearm muscle 1 day after injury and 2 weeks of physical therapy commenced at 5 days after injury. Functional evaluations were conducted 8 weeks after injury.

Results: Minocycline, either as a monotherapy or as combination treatment with botox/physical therapy significantly reduced impairments of spatial learning and memory in the water maze test, whereas botox/physical therapy reduced forelimb motor asymmetry and improved manual dexterity in the cylinder and vermicelli handling tests, A synergistic effect between the 2 treatments was observed when rats performed tasks requiring dexterity. Inflammation was attenuated in the peri-contusion cortex and hippocampus in all TBI groups receiving mono or combination therapies, though there was no significant difference in lesion size among groups.

Conclusion: These data provide a rationale for incorporating anti-inflammatory treatment during rehabilitation therapy.

Keywords: botox; constraint-induced movement therapy (CIMT); controlled cortical impact; glial fibrillary acidic protein (GFAP); microglia; rehabilitation.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Astrocytes / physiology
  • Botulinum Toxins, Type A / therapeutic use*
  • Brain / drug effects*
  • Brain / pathology
  • Brain / physiopathology
  • Brain Injuries / drug therapy
  • Brain Injuries / therapy*
  • Combined Modality Therapy
  • Disease Models, Animal
  • Drug Therapy, Combination
  • Male
  • Maze Learning / drug effects
  • Microglia / physiology
  • Minocycline / therapeutic use*
  • Physical Therapy Modalities*
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Botulinum Toxins, Type A
  • Minocycline